| 1 |
34126072 | CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10). | 2021 Aug |
1 |
| 2 |
29145976 | Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. | 2017 May |
3 |
| 3 |
27725879 | Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. | 2016 |
2 |
| 4 |
25283245 | Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids. | 2015 Feb |
2 |
| 5 |
25685543 | P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review. | 2015 Jan |
1 |
| 6 |
21374643 | Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. | 2012 Nov |
2 |
| 7 |
21680190 | 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance. | 2011 Jul 15 |
4 |
| 8 |
19442049 | Multidrug resistance through the spectacle of P-glycoprotein. | 2009 May |
3 |
| 9 |
19470292 | Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | 2009 |
1 |
| 10 |
17620438 | Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein. | 2007 Jul |
4 |
| 11 |
18528466 | The individualization of cancer therapy: the unexpected role of p53. | 2006 |
2 |
| 12 |
15457126 | Ex vivo reversal of chemoresistance by tariquidar (XR9576). | 2004 Oct |
2 |
| 13 |
20641303 | 99mTc-2-Methoxyisobutylisonitrile | 2004 |
1 |
| 14 |
20641310 | [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide | 2004 |
1 |
| 15 |
20641391 | 1-(9H-Carbazol-4-yloxy)-3-(2-(2-[11C]methoxyphenoxy)ethylamino)-propan-2-ol | 2004 |
3 |
| 16 |
20641759 | 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-[11C]methyl-amino]-2-propan-2-yl-pentanenitrile | 2004 |
3 |
| 17 |
20862794 | 6,7-Dimethoxy-2-[3-(5-[11C]methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-1,2,3,4-tetrahydro-isoquinoline | 2004 |
1 |
| 18 |
20862795 | 6,7-Dimethoxy-2-{3-[4-[11C]methoxy-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-propyl}-1,2,3,4-tetrahydro-isoquinoline | 2004 |
1 |
| 19 |
12490309 | Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol. | 2003 Jan 28 |
1 |
| 20 |
11850258 | Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. | 2002 Mar |
1 |
| 21 |
12203099 | Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate. | 2002 Sep |
3 |
| 22 |
12516967 | Identification and characterization of the canine multidrug resistance-associated protein. | 2002 Dec |
2 |
| 23 |
11552980 | Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy. | 2001 Sep |
3 |
| 24 |
10739113 | The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia. | 2000 Mar |
2 |
| 25 |
11062698 | The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC. | 2000 Sep-Oct |
1 |
| 26 |
11187897 | Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes. | 2000 Dec |
2 |
| 27 |
10092063 | MDR1 gene expression in primary and advanced breast cancer. | 1999 Mar |
2 |
| 28 |
9687882 | The multidrug resistance in human leukemias. Minireview. | 1998 |
1 |
| 29 |
9744556 | Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids. | 1998 Jul 3 |
3 |
| 30 |
9780138 | Therapeutic approach to drug resistant tumors. | 1998 Oct |
1 |
| 31 |
9864280 | Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo. | 1998 Dec |
1 |
| 32 |
10021886 | [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs]. | 1998 |
1 |
| 33 |
8546904 | Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells. | 1996 Jan |
2 |
| 34 |
8599869 | Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. | 1996 |
1 |
| 35 |
8704189 | Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. | 1996 Jul 1 |
2 |
| 36 |
9816243 | Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells. | 1996 May |
1 |
| 37 |
7540457 | Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis. | 1995 Feb |
1 |
| 38 |
7598747 | Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. | 1995 Jun 16 |
1 |
| 39 |
7734315 | Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. | 1995 May |
1 |
| 40 |
8669809 | Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. | 1995 Nov-Dec |
1 |
| 41 |
7807193 | Drug resistance in brain tumors. | 1994 |
1 |
| 42 |
7909572 | Clinical relevance of P-glycoprotein expression in haematological malignancies. | 1994 Apr |
1 |
| 43 |
7912754 | Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis. | 1994 Jul |
2 |
| 44 |
7915508 | In vivo expression of P-glycoprotein in a human colon carcinoma xenograft is modulated by therapy with free and monoclonal antibody-conjugated vinca alkaloids. | 1994 May-Jun |
1 |
| 45 |
7681059 | Human P-glycoprotein transports cyclosporin A and FK506. | 1993 Mar 25 |
1 |
| 46 |
7765326 | Multidrug resistance (MDR) genes in haematological malignancies. | 1993 |
1 |
| 47 |
7765329 | Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. | 1993 |
1 |
| 48 |
8094716 | The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1. | 1993 Feb 20 |
1 |
| 49 |
1334113 | Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. | 1992 Nov |
1 |
| 50 |
1348013 | Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. | 1992 Apr 1 |
1 |